"The funds provided by Active Against ALS significantly aided in a
collaborative project looking at how stress impacts production of these toxic proteins. This work would not have been done without the support of
Active Against ALS and our results will soon be published.
They suggest that targeting the stress pathways directly are unlikely
tofix the underlying problems - meaning that we need to target our
therapeutic strategies at an earlier stage in the pathogenic cascade."
- Dr. Peter Todd
Ann Arbor VA Medical Center & University of Michigan